首页> 外文OA文献 >The NETPET Score: Combining FDG and Somatostatin Receptor Imaging for Optimal Management of Patients with Metastatic Well-Differentiated Neuroendocrine Tumors

【2h】

The NETPET Score: Combining FDG and Somatostatin Receptor Imaging for Optimal Management of Patients with Metastatic Well-Differentiated Neuroendocrine Tumors

机译：内网分：组合FDG和生长抑素受体成像，以获得转移性良好分化的神经内分泌肿瘤患者的最佳管理

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Elif Hindié;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The NETPET Score: Combining FDG and Somatostatin Receptor Imaging for Optimal Management of Patients with Metastatic Well-Differentiated Neuroendocrine Tumors [J] . Elif Hindié Theranostics . 2017,第5期

机译：NETPET评分：结合FDG和生长抑素受体成像对转移性高分化神经内分泌肿瘤患者的最佳治疗
2. Does PRRT with standard activities of 177Lu-octreotate really achieve relevant somatostatin receptor saturation in target tumor lesions?: insights from intra-therapeutic receptor imaging in patients with metastatic gastroenteropancreatic neuroendocrine tumors [J] . Amir Sabet, James Nagarajah, Ahmet Semih Dogan, EJNMMI Research . 2013,第1期

机译：PRRT的标准活性为177Lu-奥曲肽是否真的能在目标肿瘤病变中达到相关的生长抑素受体饱和度？：转移性胃肠内胰腺神经内分泌肿瘤患者治疗中受体影像的见解
3. Does PRRT with standard activities of 177Lu-octreotate really achieve relevant somatostatin receptor saturation in target tumor lesions?: insights from intra-therapeutic receptor imaging in patients with metastatic gastroenteropancreatic neuroendocrine tumors [J] . Amir Sabet, James Nagarajah, Ahmet S Dogan, EJNMMI Research . 2013,第1期

机译：PRRT的标准活性为177Lu-奥曲肽是否真的能在目标肿瘤病变中达到相关的生长抑素受体饱和度？：转移性胃肠内胰腺神经内分泌肿瘤患者治疗中受体成像的见解
4. The role of whole body F-18-FDG PET as screening tool in patients with suspected metastatic brain tumor [C] . The First China-Japan-Korea conference of nuclear medicine . 2002

机译：全身F-18-FDG PET作为疑似转移性脑肿瘤患者的筛查工具的作用
5. ISL-1 Expression as a Potential Prognostic Factor in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumors [D] . Assi, Hussein. 2020

机译：ISL-1表达作为具有良好分化的胰腺神经内分泌肿瘤患者的潜在预后因素
6. The NETPET Score: Combining FDG and Somatostatin Receptor Imaging for Optimal Management of Patients with Metastatic Well-Differentiated Neuroendocrine Tumors [O] . Elif Hindié 2017

机译：NETPET评分：结合FDG和生长抑素受体成像对转移性高分化神经内分泌肿瘤患者的最佳治疗
7. Does PRRT with standard activities of 177Lu-octreotate really achieve relevant somatostatin receptor saturation in target tumor lesions?: insights from intra-therapeutic receptor imaging in patients with metastatic gastroenteropancreatic neuroendocrine tumors [O] . Amir Sabet, James Nagarajah, Ahmet Dogan, 2013

机译：PRRT的标准活性为177Lu-奥曲肽是否真的能在靶肿瘤病变中达到相关的生长抑素受体饱和度？

The NETPET Score: Combining FDG and Somatostatin Receptor Imaging for Optimal Management of Patients with Metastatic Well-Differentiated Neuroendocrine Tumors

著录项

引文网络

相似文献

相关主题

期刊订阅